FinanceStock Analysis

Cencora (COR) Institutional Holdings and Analyst Ratings

9 months agoUS
Cencora (COR) Institutional Holdings and Analyst RatingsSource: marketbeat.com
This article examines recent institutional investor activity and analyst ratings for Cencora, Inc. (COR), a pharmaceutical sourcing and distribution company. Understanding these trends can provide valuable insights into the stock's potential performance.

Key Insights

Several institutional investors adjusted their positions in Cencora during Q1 and Q2 2025.

Wedge Capital Management L L P NC reduced its stake by 8.9%, while Fulton Bank N.A. decreased its holdings by 17.7%.

Livforsakringsbolaget Skandia Omsesidigt significantly reduced its holdings by 95.2%.

Other firms like GAMMA Investing LLC, Invesco Ltd., and T. Rowe Price Investment Management Inc. increased their positions substantially.

Cencora reported strong Q3 2025 earnings, beating EPS estimates by $0.21 with revenue up 8.7% year-over-year.

The company announced a quarterly dividend of $0.55 per share, yielding 0.8% annually.

Analysts have a "Moderate Buy" rating on Cencora, with an average price target of $311.25.

Why this matters: Institutional investment trends can indicate the long-term confidence in a stock. Positive earnings reports and dividend announcements can attract investors, while analyst ratings offer a consensus view on future stock performance.

In-Depth Analysis

Cencora (NYSE:COR) has seen notable activity from institutional investors recently. Wedge Capital Management L L P NC reduced its stake by 8.9%, holding 109,812 shares valued at $32,927,000?ref=yanuki.com. Fulton Bank N.A. decreased its position by 17.7%, owning 4,154 shares worth $1.25 million?ref=yanuki.com. Livforsakringsbolaget Skandia Omsesidigt significantly slashed its holdings by 95.2%, retaining only 1,875 shares valued at $562,000?ref=yanuki.com.

Conversely, GAMMA Investing LLC increased its holdings by 43,561.9%, now owning 1,598,461 shares valued at $444,516,000?ref=yanuki.com. Invesco Ltd. boosted its stake by 42.1%, holding 4,607,964 shares worth $1,281,429,000?ref=yanuki.com. T. Rowe Price Investment Management Inc. increased its position by 4,459.6%, now owning 997,233 shares valued at $277,321,000?ref=yanuki.com. Price T Rowe Associates Inc. MD also increased its holdings by 8.9%, owning 9,647,310 shares valued at $2,682,821,000?ref=yanuki.com. Nuveen LLC established a new stake valued at $181,284,000?ref=yanuki.com.

Cencora reported strong Q3 2025 results, with EPS at $4.00, surpassing estimates of $3.79. Revenue grew by 8.7% year-over-year to $80.66 billion?ref=yanuki.com. The company declared a quarterly dividend of $0.55 per share, or $2.20 annualized, with a yield of 0.8%?ref=yanuki.com.

Analysts from Jefferies Financial Group, Wells Fargo & Company, and Morgan Stanley have weighed in on the stock, with price targets ranging from $300.00 to $354.00?ref=yanuki.com. The consensus rating is "Moderate Buy," with an average price target of $311.25, according to MarketBeat.com?ref=yanuki.com.

Insiders have also been active, with Chairman Steven H. Collis and CEO Robert P. Mauch selling shares in recent months?ref=yanuki.com.

FAQs

Q: What was Cencora's EPS for the last quarter?

Cencora reported $4.00 EPS for the quarter, beating analyst estimates of $3.79.

Q: What is Cencora's current dividend yield?

Cencora's dividend yield is 0.8%, with a quarterly dividend of $0.55 per share.

Q: What is the analyst consensus rating for Cencora?

Cencora has a "Moderate Buy" rating, with an average price target of $311.25.

Key Takeaways

Monitor institutional investment trends to gauge long-term confidence in Cencora.

Consider analyst ratings and price targets as part of your investment decision-making process.

Stay informed about insider trading activity, which can provide additional insights.

Cencora’s strong earnings and dividend payouts may make it an attractive investment option.

Discussion

Do you think Cencora is a strong buy based on recent institutional activity and analyst ratings? Let us know!

Share this article with others who need to stay ahead of this trend!

Related Articles

⚠ Disclaimer: Yanuki provides article summaries and links for reference only. Yanuki does not endorse, verify, or guarantee the accuracy of third-party sources. Please review original sources and verify information independently. Managed by the Yanuki Data Engine. Full Disclaimer